¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"area monitoring"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® fetal monitoring ÇÑ±Û Å¾ư¨½Ã
¼³¸í   
  ÀӽŠÁßÀ̳ª ºÐ¸¸ ÁßÀǠžÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ» Å¾ư¨½Ã¶ó°í ÇÑ´Ù. ¿©±â¿¡´Â ¿©·¯ °¡Áö ¹æ¹ýÀÌ Àִµ¥ Å©°Ô ºÐ¸¸Àü Å¾ư¨½Ã¿Í ºÐ¸¸Áߠžư¨½Ã·Î Å©°Ô ³ª´«´Ù.
  
  1. ºÐ¸¸Àü Å¾ư¨½Ã´Â ºÐ¸¸Çϱâ ÀÌÀüÀǠžÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀ¸·Î ´ÙÀ½°ú °°Àº ¿©·¯ °¡Áö ¹æ¹ýÀÌ ÀÖ´Ù.
  
    1)¾ç¼öõÀÚ-ÁÖ»ç±â¸¦ ÀÌ¿ëÇØ¼­ »ê¸ðÀÇ ¹è¸¦ ÅëÇØ¼­ ¾ç¼ö¸¦ ¾ò¾î¼­ ºÐ¼®ÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â ¹æ¹ý. ÀӽŠ15ÁÖ À̻󿡼­ ½Ç½ÃÇÒ ¼ö°¡ ÀÖ´Ù.
  
    2)ÅÈÁÙõÀÚ-ÃÊÀ½ÆÄ°Ë»ç¸¦ ½Ç½ÃÇÏ¿© ¿µ»óÀ» º¸¸é¼­ ÅÈÁÙ¼Ó¿¡ ¹Ù´ÃÀ» ³Ö¾î¼­ ±×°÷ÀÇ Ç÷°üÀ» Ã£¾Æ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»çÇϴ ¹æ¹ý.
  
    3)½ºÆ®·¹½º°Ë»ç-žƵµ Àڱüӿ¡¼­ ¿îµ¿À» ÇÑ´Ù. ±×¸®°í Á¤»óÀûÀ¸·Î Å¾ư¡ Àڱüӿ¡¼­ ¿îµ¿À» ÇÒ °æ¿ì¿¡´Â Å¾ÆÀÇ ½ÉÀå ¹Úµ¿ÀÌ »¡¶óÁö°Ô µÈ´Ù. Å¾ÆÀÇ ¿îµ¿°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿À» µ¿½Ã¿¡ °¨½ÃÇÏ¿© ¿îµ¿½Ã¿¡ Å¾ÆÀÇ ½ÉÀå¹Úµ¿ÀÌ »¡¶óÁö´Â °¡¸¦ ¾Ë¾Æº¸´Â °ÍÀÌ´Ù.
  
    4)žÆÃ»°¢Àڱذ˻ç-30ÁÖ ÀÌ»óÀÌ µÈ Å¾ƴ ¼Ò¸®ÀÇ Àڱؿ¡ ´ëÇØ¼­ ¹ÝÀÀÀ» ÇÑ´Ù. Áï ¼Ò¸®¸¦ µé·ÁÁÖ¾úÀ» °æ¿ì¿¡ Å¾ư¡ ¹ÝÀÀÀ» Çؼ­ ½ÉÀåÀÇ ¹Úµ¿¼ö°¡ Áõ°¡¸¦ ÇÑ´Ù.
  
    5)¼öÃེƮ·¹½º°Ë»ç-Á¤»óÀûÀΠžƴ ÀÚ±ÃÀÌ ¼öÃàÇϸé ÀÌ¿¡ ¹ÝÀÀÀ» Çؼ­ ½É¹Ú¼ö°¡ º¯È­ÇÑ´Ù. À̰ÍÀ» ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ °Ë»çÇϴ ¹æ¹ýÀÌ´Ù.
  
  2. ºÐ¸¸Áߠžư¨½Ã
  
  ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ °Ç°­»óŸ¦ °¨½ÃÇϴ °ÍÀÌ´Ù. ´ëü·Î ºÐ¸¸µµÁß¿¡ Å¾ư¡ Àú»ê¼ÒÁõÀ̳ª ¿©·¯ °¡Áö Ãæ°ÝÀ» ¹Þ´Â °æ¿ì°¡ ¸¹À¸¹Ç·Î ºÐ¸¸µµÁßÀǠžư¨½Ã´Â Áß¿äÇÑ Àǹ̸¦ °¡Áø´Ù.
  
    1)ÀüÀڽĞư¨½Ã-Àü±âÀû ÀåÄ¡¸¦ ÀÌ¿ëÇÏ¿© Å¾ÆÀÇ »óŸ¦ ¾Ë¾Æº¸´Â °ÍÀ¸·Î °¨½ÃÀÇ ´ë»óÀº ÀÚ±ÃÀÇ ¼öÃà°ú Å¾ÆÀÇ ½ÉÀå¹Úµ¿¼öÀÌ´Ù.
  
    2)žƸӸ®µ¤°³ Ç¥º»Ã¤Ãë Ç÷¾×-ºÐ¸¸µµÁß¿¡ Å¾ÆÀÇ µÎÇÇÀÇ Ç÷°ü¿¡¼­ Ç÷¾×À» Ã¤ÃëÇÏ¿© °Ë»ç¸¦ ÅëÇØ¼­ Å¾ÆÀÇ »óŸ¦ ¾Æ´Â ¹æ¹ýÀÌ´Ù. ÁַΠ°Ë»ç¸¦ ÇàÇϴ Á¾¸ñÀº Ç÷¾×ÀÇ pHÀÌ´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • area monitoring
    ±¸¿ª°¨½Ã
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • air monitoring
    ´ë±â°¨½Ã
  • blood glucose monitoring
    Ç÷´ç°¨½Ã
  • central venous pressure monitoring
    Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
  • drug level monitoring
    ¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
  • fetal monitoring
    žư¨½Ã, žƸð´ÏÅ͸µ
  • hemodynamic monitoring
    Ç÷¿ªÇа¨½Ã, Ç÷¿ªÇиð´ÏÅ͸µ
  • invasive monitoring
    ħ½À°¨½Ã
  • individual monitoring
    °³Àθð´ÏÅ͸µ
  • intraoperative monitoring
    ¼ö¼úÁß°¨½Ã
  • monitoring
    °¨½Ã, ¸ð´ÏÅ͸µ
  • metabolic monitoring
    ´ë»ç·®Á¶»ç
  • neuromuscular monitoring
    ½Å°æ±Ù(À°)°¨½Ã
  • noninvasive monitoring
    ºñħ½À°¨½Ã
  • personal monitoring
    1. °³Àΰ¨½Ã 2. °³Àμ±·®°¨½Ã
  • quality monitoring
    Áú°¨½Ã
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • monitoring
    °¨½Ã
  • therapeutic drug monitoring
    Ä¡·á¾à¹°³óµµ°¨½Ã
  • area
    ±¸¿ª, ¿µ¿ª, ¿ª, ºÎÀ§, ºÎ, ¸éÀû
  • area cribrosa
    ü±¸¿ª
  • area postrema
    ¸Ç¾Æ·¡±¸¿ª
  • inguinal area
    »ô±¼ºÎÀ§, ¼­ÇýºÎ
  • preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
  • subareolar area
    Á¥²ÉÆÇ¹ØºÎÀ§, À¯·ûÇϺÎ
  • supporting area
    ÁöÁöºÎ
  • surface area
    üǥ¸éÀû, Ç¥¸éÀû
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • area monitoring
    ±¸¿ª°¨½Ã
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • air monitoring
    ´ë±â°¨½Ã
  • central venous pressure monitoring
    Áß½ÉÁ¤¸Æ¾Ð°¨½Ã
  • chemotherapeutic drug monitoring
    È­Çпä¹ý¾àÁ¦°¨½Ã
  • drug level monitoring
    ¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
  • fetal monitoring
    žư¨½Ã
  • glucose monitoring
    Æ÷µµ´ç°¨½Ã
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý°¨½Ã
  • individual monitoring
    °³Àθð´ÏÅ͸µ
  • intraoperative monitoring
    ¼ö¼úÁß°¨½Ã
  • invasive monitoring
    ħ½À°¨½Ã
  • monitoring
    °¨½Ã
  • metabolic monitoring
    ´ë»ç·®Á¶»ç
  • neuromuscular monitoring
    ½Å°æ±ÙÀ°°¨½Ã
  • noninvasive monitoring
    ºñħ½À°¨½Ã
  • personal monitoring
    °³À਽Ã, °³Àμ±·®°¨½Ã
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • area monitoring
    ±¸¿ª<¹æ»çÇÇÆø>°¨½Ã.
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • TDM : therapeutic drug monitoring
    Ä¡·á¾à¹°³óµµ ¸ð´ÏÅ͸µ.
  • air monitoring
    ´ë±â¿À¿°°¨½Ã(ËÀË»ËçËç˧Ëà).
  • glucose monitoring
    Æ÷µµ´ç°¨½Ã
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
  • individual monitoring
    °³Àθð´ÏÅ͸µ
  • personal monitoring
    °³ÀÎ (ÇÇÆø)°¨½Ã
  • personal monitoring
    °³Àμ±·®°¨½Ã
  • quality monitoring
    Á¤µµ°ü¸®°¨½Ã
  • radiation monitoring
    ¹æ»ç¼±°¨½Ã
  • AUC : area under the concentration-time curve
    Ç÷Áß(¾à¹°)³óµµ°î¼±ÇϸéÀû.
  • Brocas area
    ºê·ÎÄ«¿µ¿ª.
  • Brocas area
    ºê·ÎÄ«¿µ¿ª
  • Brocas speech area
    ºê·ÎÄ«¾ð¾î¿µ¿ª
  • Brodmanns area
    ºê·Îµå¸¸ ¿µ¿ª(çÐæ´)
  • Frontal association area
    ÀüµÎ¿¬ÇÕ¾ß(îñÔéÖ¤ùêå¯)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • area monitoring
    ±¸¿ª<¹æ»çÇÇÆø>°¨½Ã.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • cochlear area, =area cochleae <³ª>
    ¿Í¿ì¿µ¿ª, ´ÞÆØÀ̽Ű汸¿ª{ÇØ}
  • cochlear area<³ª> area cochleae
    ´ÞÆØÀ̽Ű汸¿ª, ¿Í¿ì¾ß(èÄéÚå¯).
  • supplemental motor area = supplementary area
    º¸Á¶¿îµ¿¿µ¿ª(ÜÍð¾ê¡ÔÑçÐæ´)
  • air monitoring
    ´ë±â¿À¿°°¨½Ã(ËÀË»ËçËç˧Ëà).
  • behavior monitoring program
    Çൿ(ÇàÅÂ)°¨½ÃÇÁ·Î±×·¥
  • chemotherapeutic drug monitoring
    È­Çпä¹ý¾àÁ¦°¨½Ã
  • drug level monitoring
    ¾à¹°³óµµ°¨½Ã, ¾à¹°³óµµÃøÁ¤
  • fetal monitoring
    žư¨½Ã.
  • glucose monitoring
    Æ÷µµ´ç°¨½Ã
  • heparin therapy monitoring
    ÇìÆÄ¸°¿ä¹ý<--Ä¡·á>°¨½Ã
  • individual monitoring
    °³Àθð´ÏÅ͸µ
  • invasive monitoring
    °üÇ÷Àû °¨½Ã.
  • metabolic monitoring
    ´ë»ç·®Á¶»ç(¡­åÖðàÞÛ).
  • monitoring
    °¨½Ã
  • neuromuscular monitoring
    ½Å°æ±Ù°¨½Ã
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Marginal area
    °¡ÀåÀÚ¸®±¸¿ª
    [¿¾ ¿ë¾î] º¯¿¬ºÎ
  • Cupula area
    ²À´ë±â±¸¿ª
    [¿¾ ¿ë¾î] ¹èºÎ
  • Subcallosal area
    ³úµéº¸¹Ø±¸¿ª
    [¿¾ ¿ë¾î] ¾çÇϾß
  • Cochlear area
    ´ÞÆØÀ̽Ű汸¿ª
    [¿¾ ¿ë¾î] ¿Í¿ì¾ß
  • Contact area
    ´ê´ÂºÎºÐ
    [¿¾ ¿ë¾î] Á¢Ã˸é
  • Posterior intercondylar area
    µÚÀ¶±â»çÀ̱¸¿ª
    [¿¾ ¿ë¾î] Èİú°£±¸
  • Area postrema
    ¸Ç¾Æ·¡±¸¿ª
    [¿¾ ¿ë¾î] ÃÖÇϾß
  • Bare area
    ¹«À帷±¸¿ª
    [¿¾ ¿ë¾î] ¹«À帷¾ß
  • Opaque area
    ºÒÅõ¸í±¸¿ª
    [¿¾ ¿ë¾î] ¾Ï¾ß[ºÎ]
  • Vesiclular area
    ¼ÒÆ÷±¸¿ª
    [¿¾ ¿ë¾î] ¼ÒÆ÷ºÎ
  • Preoptic area
    ½Ã°¢±³Â÷¾Õ±¸¿ª
    [¿¾ ¿ë¾î] ½Ã½Å°æ±³Â÷Àü¾ß
  • Cardiogenic area
    ½ÉÀå¹ß»ý±¸¿ª
    [¿¾ ¿ë¾î] ½ÉÀå¹ß»ý±¸¿ª
  • Inferior vestibular area
    ¾Æ·¡¾È¶ã½Å°æ±¸¿ª
    [¿¾ ¿ë¾î] ÇÏÀüÁ¤¾ß
  • Vestibular area
    ¾È¶ã±¸¿ª
    [¿¾ ¿ë¾î] ÀüÁ¤½Å°æ¾ß
  • Anterior intercondylar area
    ¾ÕÀ¶±â»çÀ̱¸¿ª
    [¿¾ ¿ë¾î] Àü°ú°£±¸
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 2 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • hyperendemic area
    °íµµÀ¯ÇàÁö
  • hypoendemic area
    ÀúµµÀ¯ÇàÁö
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • maximum height-area method
    Ãִ뱤¿ª¹ý(õÌÓÞÎÆæ´Ûö)
  • selected ion monitoring
    ¼±ÅÃ(àÔ÷É) À̿ ¸ð´ÏÅ͹ý(Ûö)
  • single-ion monitoring
    ´Ü(Ó¤)À̿ ¸ð´ÏÅ͸µ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • monitoring
    °¨½Ã
  • personal monitoring
    °³ÀÎ(ÇÇÆø)°¨½Ã
  • adjacent area
    ÀÎÁ¢¿ª
  • area
    ¿µ¿ª, ¾ß, Áö¿ª, ±¸
  • bare area
    ³ëÃâºÎ
  • Broca's area
    ºê·ÎÄ«¿µ¿ª
  • high echo area
    °í¿¡ÄÚ ±¸¿ª
  • LAN [=local area network]
    ±Ù°Å¸®Åë½Å¸Á, ·£
  • Lor-fitted area
    Ãִ뿵¿ª
  • low echo area
    Àú¿¡ÄÚ±¸¿ª
  • motor speech area
    ¿îµ¿¾ð¾î·É
  • postcricoid area
    À±»ó¿¬°ñÈĺÎ
  • posterior hypothalamic area
    ÈĽûóÇϺοµ¿ª
  • premotor area
    Àü¿îµ¿¿µ¿ª
  • saddle bag area
    ¸¸³²¸é
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
AHA acetohydroxamic acid; acquired hemolytic anemia; acute hemolytic anemia; American Heart Association;...
IA ibotenic acid; immune adherence; immunoadsorbent; immunobiologic activity; impedance angle; indolami...
LA50 total body surface area of burn that will kill 50% of patients (lethal area)
AFP Alpha(¥á) Feto-Protein [HP 1826, 1858, 1859, 2265]
  ; Oncofetal Antigens
 &nbs...
SMBG Self Monitoring of Blood Glucose
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ABPM Ambulatory BP monitoring
ABPM Ambulatory Blood Pressure Monitoring
AEM Ambulatory Electrocardiographic Monitoring
AIMS Australian Incident Monitoring Study
BDMP Birth Defects Monitoring Program
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • ambulatory ventricular function monitoring
    º¸Çà ½Ã ½É½Ç±â´É °¨½Ã
  • length monitoring system
    ±æÀÌ °¨Áö°è
  • monitoring device
    °¨½Ã ÀåÄ¡
  • monitoring instrument
    °¨½Ã ±â±¸
  • anesthetic area
    ¸¶Ãë ¿ª
  • anterior amygdaloid area
    ¾Õ Æíµµ ±¸¿ª
  • aortic area
    ´ëµ¿¸Æ ¸é
    ¿ìÃø Á¦ 2´Á¿¬°ñÀÇ ³»Ãø´ÜºÎ À§ÀÇ Èä°û Ç¥¸é.
  • apical area
    ±Ù÷ºÎ, Ä¡±Ù÷ºÎ, ±Ù÷´ÜºÎ, Ä¡±Ù ÷´ÜºÎ
  • area
    ¿µ¿ª, ¾ß, ±¸
    ±¹ÇÑµÈ ºÎºÐ. ƯÀÌÇÑ Ç¥¸é ºÎºÐ°ú ±â´É ºÎÀ§¸¦ Ç¥½ÃÇÏ´Â ÇØºÎÇÐ ¿ë¾î.
  • area centralis
    Áß½É¿Í ¿µ¿ª
    ¸Á¸·ÀÇ ½Å°æÀý ¼¼Æ÷Ãþ¿¡ ÀÖ´Â ¼Ò¿Í ÁÖÀ§ÀÇ ¼¼Æ÷ ¿µ¿ª.
  • area cochleae
    ¿Í¿ì ¿µ¿ª
    ¿Í¿ìÀúÀÇ ±Ù¹æ¿¡¼­ ³»À̵µÀú ÇϺÎÀÇ ¾ÕºÎºÐ.
  • area cribrosa
    ü±¸¿ª
  • area lunata
    ¿ù»ó ¿µ¿ª
    ¼Ò³ú ¹Ý±¸ÀÇ ÈĹݿù ¼Ò¿±À¸·Î¼­ ÈÄ¿ù¿±ÀÇ ¾Õ¿¡ ÀÖ´Ù.
  • area nervi facialis
    ¾È¸é ½Å°æ ¿µ¿ª
    ¾È¸é ½Å°æÀÌ ¾È¸é ½Å°æ °ü¿¡ µé¾î°¡´Â ³»À̵µÀúÀÇ ºÎºÐ.
  • area of body surface
    üǥ¸éÀû
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
biological monitoring This is the periodic examination of biological specimens for the purposes of monitoring their exposure to or the effects of potentially toxic chemicals to the environment. This is normally done by analysing the amounts of the toxic substances or their metabolites present in body tissues and fluids. The term is also used to mean assessment of the biological status of populations and communities of organisms at risk, in order to protect them and to gain an early warning of possible hazards to human health.
(09 Oct 1997)
blood gas monitoring, transcutaneous The noninvasive measurement or determination of the partial pressure (tension) of oxygen and/or carbon dioxide locally in the capillaries of a tissue by the application to the skin of a special set of electrodes. These electrodes contain photoelectric sensors capable of picking up the specific wavelengths of radiation emitted by oxygenated versus reduced haemoglobin.
(12 Dec 1998)
blood glucose monitoring A way of testing how much glucose (sugar) is in the blood. A drop of blood, usually taken from the fingertip, is placed on the end of a specially coated strip, called a testing strip. The strip has a chemical on it that makes it change colour according to how much glucose is in the blood. A person can tell if the level of glucose is low, high, or normal in one of two ways. The first is by comparing the colour on the end of the strip to a colour chart that is printed on the side of the test strip container. The second is by inserting the strip into a small machine, called a meter, which reads the strip and shows the level of blood glucose in a digital window display. Blood testing is more accurate than urine testing in monitoring blood glucose levels because it shows what the current level of glucose is, rather than what the level was an hour or so previously.
(09 Oct 1997)
blood glucose self-monitoring Self evaluation of whole blood glucose levels outside the clinical laboratory. A digital or battery-operated reflectance meter may be used. It has wide application in controlling unstable insulin-dependent diabetes.
(12 Dec 1998)
blood pressure monitoring, ambulatory Method in which prolonged blood pressure readings are made while the patient undergoes normal daily activities. It allows quantitative analysis of the high blood pressure load over time, can help distinguish between types of hypertension, and can assess the effectiveness of antihypertensive therapy.
(12 Dec 1998)
radiation monitoring The observation, either continuously or at intervals, of the levels of radiation in a given area, generally for the purpose of assuring that they have not exceeded prescribed amounts or, in case of radiation already present in the area, assuring that the levels have returned to those meeting acceptable safety standards.
(12 Dec 1998)
monitoring <investigation> The process of continually checking, observing, recording or testing the operation of some procedure. Monitoring occurs for example during anaesthesia or radiation.
(18 Nov 1997)
monitoring, ambulatory The use of electronic equipment to observe or record physiologic processes while the patient undergoes normal daily activities.
(12 Dec 1998)
monitoring, immunologic Testing of immune status in the diagnosis and therapy of cancer, immunoproliferative and immunodeficiency disorders, and autoimmune abnormalities. Changes in immune parameters are of special significance before, during and following organ transplantation. Strategies include measurement of tumour antigen and other markers (often by radioimmunoassay), studies of cellular or humoral immunity in cancer aetiology, immunotherapy trials, etc.
(12 Dec 1998)
monitoring, intraoperative The constant checking on the state or condition of a patient during the course of a surgical operation (e.g., checking of vital signs).
(12 Dec 1998)
monitoring, physiologic The continuous measurement of physiological processes, blood pressure, heart rate, renal output, reflexes, respiration, etc., in a patient or experimental animal; includes pharmacologic monitoring, the measurement of administered drugs or their metabolites in the blood, tissues, or urine.
(12 Dec 1998)
Holter monitoring <cardiology, investigation> A test which measures the heart rhythm (ECG) over a 24 hour period of time while the patient records their symptoms and activities in a diary. A small portable ECG device is worn in a pouch around the neck. After the test is complete, a correlation is made between the symptoms (or activities) recorded and the ECG pattern that was obtained simultaneously.
(27 Sep 1997)
drug monitoring The process of observing, recording, or detecting the effects of a chemical substance administered to an individual therapeutically or diagnostically.
(12 Dec 1998)
intraocular pressure monitoring <ophthalmology, technique> This is procedure which measures the pressure inside the eyes. This is a screening test for glaucoma. This test is performed by an ophthalmologist.
(27 Sep 1997)
environmental monitoring The monitoring of the level of toxicants, pollutants, or other harmful chemicals in the environment or workplace by measuring the amounts of these toxicants in the bodies of people and animals in that environment, among other methods. It also includes the measurement of environmental exposure. Humans and animals are used as indicators of toxic levels of undesirable chemicals.
(12 Dec 1998)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • radio monitoring
    ÀüÆÄ °¨½Ã
  • area
    ¸éÀû,Áö¿ª
  • Special Area
    Ưº°Áö±¸
  • area
    ¸éÀû;°ø°£;Áö¿ª;Áö¹æ;¿µ¿ª;°øÁö;¹üÀ§;ÁöÇÏ½Ç ÃâÀÔ±¸
  • area code
    ½Ã¿Ü±¹¹ø(¹Ì±¹Àº ¼ýÀÚ 3ÀÚ¸®)
  • blanket area
    (¹æ¼Û±¹ ÁÖº¯ÀÇ)³­Ã»±¸¿ª
  • catchment area (basin)
    (°­.¸øÀÇ) Áý¼ö Áö¿ª;(Çб³.º´¿ø.°üû µîÀÇ)´ã´ç(°üÇÒ)±¸¿ª
  • corps area
    ±º´Ü ÀÛÀü Áö¿ª;±º°ü±¸ 
  • culture area
    (°øÅëÀÇ)¹®È­ ¿µ¿ª
  • depressed area
    ºÒȲÁö¿ª(Áö¹æ)
  • development area
    »ê¾÷ °³¹ß Áö±¸
  • disaster area
    (¹Ì)ÀçÇØ Áö¿ª;(ÀçÇØ±¸Á¶¹ýÀÌ Àû¿ëµÇ´Â)ºñ»ó ÀçÇØ Áö±¸
  • distressed area
    ÀçÇØ Áö±¸;ºó¹Î Áö±¸
  • dollar area
    (°æ)´Þ·¯ Áö¿ª
  • dry area
    (°Ç)µå¶óÀÌ ¿¡¾î¸®¾î(ÁöÇϽÇÀÇ È¯±â,䱤À» À§ÇÏ¿© ¸¸µé¾î ³õÀº µµ¶û)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á